Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × Capecitabine × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 18 Stomach Neoplasms 11 Adenocarcinoma Of Esophagus 7 Neoplasm Metastasis 6 Triple Negative Breast Neoplasms 5 Rectal Neoplasms 5 Parkinson Disease 4, Autosomal Dominant Lewy Body 5 Esophageal Neoplasms 5 Colorectal Neoplasms 5 Colonic Neoplasms 3 Adenocarcinoma 3 Pathologic Complete Response 2 Neoplasms 2 Nasopharyngeal Carcinoma 2 Gallbladder Neoplasms 2 Cholangiocarcinoma 2 Anus Neoplasms 2 Somatostatinoma 1 Resectable Colon Cancer 1 Recurrence 1 Pancreatic Intraductal Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Neoplasm, Residual 1 Meningeal Neoplasms 1 Locally Advanced Rectal Cancer With Liver Metastases 1 Locally Advanced Rectal Cancer 1 Klatskin Tumor 1 Insulinoma 1 HIV Infections 1 HER2-positive Gastric Cancer 1

Interventions

Cyclophosphamide 6 Vincristine 5 Granulocyte Colony-Stimulating Factor 4 Filgrastim 4 Etoposide 4 Doxorubicin 4 venetoclax 3 prednylidene 3 deltacortene 3 Stem Cell Transplantation 3 Specimen Handling 3 Prednisone 3 Magnetic Resonance Spectroscopy 3 merphos 2 fludarabine phosphate 2 exifone 2 dexamethasone acetate 2 dexamethasone 21-phosphate 2 calaspargase pegol 2 auricularum 2 Whole-Body Irradiation 2 Sirolimus 2 Methylprednisolone 2 Methotrexate 2 Medrol Veriderm 2 Leucovorin 2 Dexamethasone 2 Cytarabine 2 Calcium Dobesilate 2 Azacitidine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡